Page last updated: 2024-11-08

4-nitroquinoline-1-oxide and Alloxan Diabetes

4-nitroquinoline-1-oxide has been researched along with Alloxan Diabetes in 3 studies

4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.

Research Excerpts

Excerpt	Relevance	Reference
" The aim of this work was to evaluate antidiabetic activity in Streptozotocin (STZ)-induced diabetic rats and the antioxidant effects of 3',4'-Di-O-acetyl-cis-khellactone (DOAcK), as well as its toxic potential."	1.43	Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats. ( Burgueño-Tapia, E; Cornejo-Garrido, J; Domínguez-Mendoza, EA; Ordaz-Pichardo, C, 2016)

3 other studies available for 4-nitroquinoline-1-oxide and Alloxan Diabetes

Article	Year
Antidiabetic effect, antioxidant activity, and toxicity of 3',4'-Di-O-acetyl-cis-khellactone in Streptozotocin-induced diabetic rats. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Catalase; Coumarins; Diabetes Mellitus, Experimen	2016
Diabetes enhances the expression of H-ras and suppresses the expression of EGFR leading to increased cell proliferation. Histology and histopathology, 2009, Volume: 24, Issue:5 Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Diabet	2009
Increased risk of oral cancer in diabetic animals is not associated with c-jun activation pathway. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2007, Volume: 35, Issue:8 Topics: 4-Nitroquinoline-1-oxide; Animals; Biopsy; Carcinogens; Carcinoma, Squamous Cell; Diabetes Mellitus,	2007